Sectors
IRMD
IRadimed Corporation
94.07
1 x 93.62
2 x 95.25
bid
ask
-
0.90
0.95%
10:02 AM
timesize
| Ytd | -3.30% | |
| 1y | 67.09% |
93.50
day range
96.68
55.11
52 week range
107.90
| Open | 94.75 | Prev Close | 94.97 | Low | 93.50 | High | 96.68 | Mkt Cap | 1.21B |
| Vol | 3.11K | Avg Vol | 137.17K | EPS | 1.99 | P/E | 47.72 | Forward P/E | 41.15 |
| Beta | 0.90 | Short Ratio | 4.59 | Inst. Own | 61.25% | Dividend | 0.80 | Div Yield | 0.82 |
| Ex Div Date | 05-15 | Earning | 07-30 | 50-d Avg | 93.09 | 200-d Avg | 92.65 | 1yr Est | 118.00 |
| Income Statement | |||
| Total Revenue | 21.98M | ||
| Revenues (USD) | 21.98M | ||
| Cost of Revenue | 5.17M | ||
| Gross Profit | 16.81M | ||
| Operating Expenses | 9.58M | ||
| Research and Development Expense | 956.00K | ||
| Selling, General and Administrative Expense | 8.62M | ||
| Operating Income | 7.24M | ||
| Income Tax Expense | 1.95M | ||
| Net Income | 5.82M | ||
| Net Income Common Stock | 5.82M | ||
| Net Income Common Stock (USD) | 5.82M | ||
| Consolidated Income | 5.82M | ||
| Earnings per Basic Share | 0.46 | ||
| Earnings per Basic Share (USD) | 0.46 | ||
| Earnings per Diluted Share | 0.45 | ||
| Dividends per Basic Common Share | 0.20 | ||
| Earning Before Interest & Taxes (EBIT) | 7.77M | ||
| Earning Before Interest & Taxes (USD) | 7.77M | ||
| Weighted Average Shares | 12.78M | ||
| Weighted Average Shares Diluted | 12.87M | ||
| Balance Sheet | |||
| Cash and Equivalents | 56.37M | ||
| Cash and Equivalents (USD) | 56.37M | ||
| Trade and Non-Trade Receivables | 13.42M | ||
| Current Assets | 86.42M | ||
| Property, Plant & Equipment Net | 24.23M | ||
| Total Assets | 114.39M | ||
| Current Liabilities | 12.12M | ||
| Total Liabilities | 15.88M | ||
| Accumulated Retained Earnings (Deficit) | 67.49M | ||
| Shareholders Equity | 98.51M | ||
| Shareholders Equity (USD) | 98.51M | ||
| Assets Non-Current | 27.97M | ||
| Deferred Revenue | 7.15M | ||
| Goodwill and Intangible Assets | 3.29M | ||
| Inventory | 11.88M | ||
| Liabilities Non-Current | 3.76M | ||
| Trade and Non-Trade Payables | 2.18M | ||
| Tax Assets | 3.36M | ||
| Tax Liabilities | 4.33M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 455.00K | ||
| Net Cash Flow from Financing | -2.61M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 5.22M | ||
| Capital Expenditure | -469.00K | ||
| Payment of Dividends & Other Cash Distributions | -2.56M | ||
| Net Cash Flow from Investing | -469.00K | ||
| Net Cash Flow from Operations | 8.29M | ||
| Share Based Compensation | 684.00K | ||